The size of the Asia Pacific Cell Fractionation Market was valued at USD 0.69 Billion in 2020. This value is further estimated to be growing at a CAGR of 10.7% and worth USD 1.15 Billion by 2025.
The market is projected to show significant growth during the forecasting period and will continue to grow in the following years because of the biotechnology sector's ongoing development.
Cell fractionation, or in other terms, Cell Lysis, is the process that separates cellular parts yet completely retains the independent features of each of them. It involves the breaking of the cell membrane by different mechanisms. Cell fractionation facilitates the study of various parts of cells individually, and scientists can thus find out their biochemical function and structure.
The major driving forces of the growth of the Cell Fractionation market in the Asia Pacific are increasing the aged population, stabilizing the economy, and developing in the biotechnology sector. The major constraints for this market's growth are the high requirement of capital and time, lack of government support, and lack of skilled expertise.
This research report has been segmented and sub-segmented the Asia Pacific Cell Fractionation Market into the following categories.
By Product:
By Cell Type:
By End User:
By Country:
Some of the notable companies operating in the Asia pacific cell fractionation market profiled in the report are Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffman-La Roche AG, Merck KGaA, Miltenyi Biotec, QIAGEN N., Qsonica and Thermo Fisher Scientific Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.3 Reagents
5.1.3.1 Enzymes
5.1.3.2 Detergent Solutions
5.1.4 Beads
5.1.5 Disposables
5.1.6 Instruments
5.1.6.1 Sonicator
5.1.6.2 Homogenizer
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Type of cell
5.2.1 Introduction
5.2.2 Microbial
5.2.3 Mammalian
5.2.4 Y-o-Y Growth Analysis, By Type of cell
5.2.5 Market Attractiveness Analysis, By Type of cell
5.2.6 Market Share Analysis, By Type of cell
5.3 End Users
5.3.1 Introduction
5.3.2 Research Laboratories and Institutes
5.3.3 Biopharmaceutical Companies
5.3.4 iotechnology Companies
5.3.5 Y-o-Y Growth Analysis, By End Users
5.3.6 Market Attractiveness Analysis, By End Users
5.3.7 Market Share Analysis, By End Users
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Beckman Coulter
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton
8.3 Dickinson and Company
8.4 Bio-Rad Laboratories
8.5 Cell Signaling Technology
8.6 Miltenyi Biotec
8.7 Thermo Fisher Scientific Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
Related Reports
Feb 2020
